Back to search
FDAFDA · Food and drugs·Recall number D-0019-2023

Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10

Published November 2, 2022 · Recall initiated: September 29, 2022

Summary

FDA records drug Class I recall D-0019-2023, published November 2, 2022 and initiated September 29, 2022. Recalling firm: Golden State Medical Supply Inc.; Status: Terminated; Reported quantity: 2,584 Bottles; Lot: Lot #: GS046745, Exp 12/2023. Class I means a reasonable probability of serious adverse health consequences or death.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

What to do

Voluntary: Firm initiated · Letter

Get an email if ATENOLOL has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
ATENOLOL
Manufacturer
Golden State Medical Supply Inc.
Distributor
USA Nationwide
Lot
Lot #: GS046745, Exp 12/2023
Risk classification
Class I
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Atenolol Tablets, USP, 25 mg, 1000-count bottle, Rx only, Manufactured by: ALPHAPHARM PTY LTD, Marketed by: GSMS, Incorporated, Camarillo, CA 93012, USA, NDC 60429-027-10 recalled?

Yes. FDA published recall D-0019-2023 on November 2, 2022. Reported hazard: Label Mix - up; a bottle labeled as Atenolol 25mg Tablets contained Clopidogrel 75mg Tablets

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: ATENOLOL.